Market Overview:
The global IVF market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of infertility, rising awareness about assisted reproductive technologies (ARTs), and technological advancements in the field of IVF. The global IVF market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into intracytoplasmic sperm injection (ICSI), frozen embryo replacement (FER), and pre-implantation genetic diagnosis (PGD). The ICSI segment is expected to account for a major share of the global IVF market owing to its high efficacy rates.
Product Definition:
In-Vitro Fertilization (IVF) is a fertility treatment in which sperm and eggs are fertilized outside the body. IVF is the most common type of assisted reproductive technology (ART).
Intracytoplasmic Sperm Injection (ICSI):
Intracytoplasmic sperm injection (ICSI) is a procedure wherein a single sperm is injected into an ovum. The success rate of this technique in the ART (Artificial Insemination Treatment) market is more than 90%. ICSI procedures are used for infertility treatment and can also be used in cases of Polycystic Ovary Syndrome (PCOS).
Frozen Embryo Replacement (FER):
Frozen embryo replacement (FER) is a process of retrieving multiple embryos from the storage and transferring to the uterus for implantation. This process is done to increase the chances of pregnancy after one or several failed IVF cycles. The number of embryos can vary between 2-4 per cycle, with a maximum total number of 10-12 transferred per patient.
The FER technique was first introduced in 2010 by an international team led by Dr.
Application Insights:
The global market is categorized into three applications namely clone, embryonic stem cell isolation and culture, and test tube baby. The embryo transfer segment dominated the overall market in terms of revenue in 2017 owing to a rise in assisted reproductive technology procedures such as IVF for female infertility. Moreover, an increase in the adoption of advanced techniques such as intracytoplasmic sperm injection (ICSI) has fueled the growth of this segment.
The test tube baby application is anticipated to witness lucrative growth over the forecast period due to technological advancements that have led to an increase in embryo transfers through artificial Insemination (AI), also known as laboratory-assisted reproduction technique or manmade womb procedure.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of IVF clinics and high adoption rate for technologically advanced procedures are some factors attributing to its largest share. In addition, government support for R&D on infertility treatments is also expected to boost the regional market over the forecast period. For instance, as part of its efforts towards improving access to fertility care, Health Canada funds several research projects on human reproduction undertaken by various organizations such as Guttmacher Institute and Canadian Fertility Society (CFS).
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to increasing awareness about IVF treatment among people in this region coupled with growing disposable income levels. Moreover, government initiatives aimed at boosting population control through artificial means are further propelling demand for these services in this region which will result into increased investments by industry players over coming years.
Growth Factors:
- Increasing infertility rates: The infertility rates are increasing due to various reasons such as lifestyle changes, stress, and pollution. This is driving the demand for IVF services.
- Advances in technology: The advances in technology are helping to improve the success rates of IVF procedures. This is attracting more patients to opt for these treatments.
- Growing awareness about IVF: There is growing awareness about the benefits of IVF among couples who are struggling with infertility issues. This is boosting the demand for these services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
IVF Market Research Report
By Type
Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)
By Application
Clone, Transgenic, Embryonic Stem Cell Isolation and Culture, Test Tube Baby
By Companies
Vitrolife AB, EMD Serono Inc, Irvine scientific, Cooper Surgical Inc, Cook Medical Inc, Thermo Fisher Scientific Inc, Genea Biomedx, Auxogyn, Inc, Oxford Gene Technology, Ovascience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global IVF Market Report Segments:
The global IVF market is segmented on the basis of:
Types
Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clone, Transgenic, Embryonic Stem Cell Isolation and Culture, Test Tube Baby
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Vitrolife AB
- EMD Serono Inc
- Irvine scientific
- Cooper Surgical Inc
- Cook Medical Inc
- Thermo Fisher Scientific Inc
- Genea Biomedx
- Auxogyn, Inc
- Oxford Gene Technology
- Ovascience
Highlights of The IVF Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intracytoplasmic Sperm Injection (ICSI)
- Frozen Embryo Replacement (FER)
- Pre-implantation Genetic Diagnosis (PGD)
- By Application:
- Clone
- Transgenic
- Embryonic Stem Cell Isolation and Culture
- Test Tube Baby
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVF Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro fertilization (IVF) is a process by which eggs are retrieved from a woman and then fertilized with sperm outside the body. The resulting embryos are then transferred back into the womanu2019s uterus to develop into babies.
Some of the major companies in the ivf market are Vitrolife AB, EMD Serono Inc, Irvine scientific, Cooper Surgical Inc, Cook Medical Inc, Thermo Fisher Scientific Inc, Genea Biomedx, Auxogyn, Inc, Oxford Gene Technology, Ovascience.
The ivf market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVF Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 IVF Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 IVF Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the IVF Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global IVF Market Size & Forecast, 2018-2028
4.5.1 IVF Market Size and Y-o-Y Growth
4.5.2 IVF Market Absolute $ Opportunity
Chapter 5 Global IVF Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 IVF Market Size Forecast by Type
5.2.1 Intracytoplasmic Sperm Injection (ICSI)
5.2.2 Frozen Embryo Replacement (FER)
5.2.3 Pre-implantation Genetic Diagnosis (PGD)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global IVF Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 IVF Market Size Forecast by Applications
6.2.1 Clone
6.2.2 Transgenic
6.2.3 Embryonic Stem Cell Isolation and Culture
6.2.4 Test Tube Baby
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IVF Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IVF Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America IVF Analysis and Forecast
9.1 Introduction
9.2 North America IVF Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America IVF Market Size Forecast by Type
9.6.1 Intracytoplasmic Sperm Injection (ICSI)
9.6.2 Frozen Embryo Replacement (FER)
9.6.3 Pre-implantation Genetic Diagnosis (PGD)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America IVF Market Size Forecast by Applications
9.10.1 Clone
9.10.2 Transgenic
9.10.3 Embryonic Stem Cell Isolation and Culture
9.10.4 Test Tube Baby
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe IVF Analysis and Forecast
10.1 Introduction
10.2 Europe IVF Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe IVF Market Size Forecast by Type
10.6.1 Intracytoplasmic Sperm Injection (ICSI)
10.6.2 Frozen Embryo Replacement (FER)
10.6.3 Pre-implantation Genetic Diagnosis (PGD)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe IVF Market Size Forecast by Applications
10.10.1 Clone
10.10.2 Transgenic
10.10.3 Embryonic Stem Cell Isolation and Culture
10.10.4 Test Tube Baby
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific IVF Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific IVF Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific IVF Market Size Forecast by Type
11.6.1 Intracytoplasmic Sperm Injection (ICSI)
11.6.2 Frozen Embryo Replacement (FER)
11.6.3 Pre-implantation Genetic Diagnosis (PGD)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific IVF Market Size Forecast by Applications
11.10.1 Clone
11.10.2 Transgenic
11.10.3 Embryonic Stem Cell Isolation and Culture
11.10.4 Test Tube Baby
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America IVF Analysis and Forecast
12.1 Introduction
12.2 Latin America IVF Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America IVF Market Size Forecast by Type
12.6.1 Intracytoplasmic Sperm Injection (ICSI)
12.6.2 Frozen Embryo Replacement (FER)
12.6.3 Pre-implantation Genetic Diagnosis (PGD)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America IVF Market Size Forecast by Applications
12.10.1 Clone
12.10.2 Transgenic
12.10.3 Embryonic Stem Cell Isolation and Culture
12.10.4 Test Tube Baby
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) IVF Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) IVF Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) IVF Market Size Forecast by Type
13.6.1 Intracytoplasmic Sperm Injection (ICSI)
13.6.2 Frozen Embryo Replacement (FER)
13.6.3 Pre-implantation Genetic Diagnosis (PGD)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) IVF Market Size Forecast by Applications
13.10.1 Clone
13.10.2 Transgenic
13.10.3 Embryonic Stem Cell Isolation and Culture
13.10.4 Test Tube Baby
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IVF Market: Competitive Dashboard
14.2 Global IVF Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Vitrolife AB
14.3.2 EMD Serono Inc
14.3.3 Irvine scientific
14.3.4 Cooper Surgical Inc
14.3.5 Cook Medical Inc
14.3.6 Thermo Fisher Scientific Inc
14.3.7 Genea Biomedx
14.3.8 Auxogyn, Inc
14.3.9 Oxford Gene Technology
14.3.10 Ovascience
